×

Cyclopropanamine compound and use thereof

  • US 9,920,047 B2
  • Filed: 09/20/2016
  • Issued: 03/20/2018
  • Est. Priority Date: 04/11/2014
  • Status: Active Grant
First Claim
Patent Images

1. A method for the treatment of Kabuki syndrome in a mammal, comprising administering an effective amount of 5-((1R,2R)-2-((cyclopropylmethyl)amino)cyclopropyl)-N-(tetrahydro-2H-pyran-4-yl)thiophene-3-carboxamide, or a salt thereof to the mammal.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×